Orion Health Named a Leader in Health Information Exchange in IDC MarketScape Report

Orion Health HIE Praised as Flexible and Configurable for a Wide Range of Customer Needs and Capabilities

Orion Health Named a Leader in Health Information Exchange in IDC MarketScape Report

Waggener Edstrom WorldwideMelissa O'Dowd, 617-234-4100orOrion HealthAlicia J. Allen, 857-210-7129

, the leader in (HIE) and , today announced that it has been named to the Leader category in IDC's MarketScape Vendor Assessment report, entitled "U.S. Health Information Exchange Platform Solutions 2012 Vendor Assessment, doc #HI235816." The company is one of six vendors included in the Leader category, which represents those vendors who ranked highest in the assessment of the market. Orion Health is also one of only two vendors in the category that is experiencing growth faster than the overall HIE market.

The MarketScape report, which was published in July 2012, evaluated 16 vendors which were selected based on their market share and potential for growth. The report cites Orion Health as having a number of key differentiators that account for its position within the Leader category; including its deep experience with more than 30 HIE customers worldwide. Additionally, it highlights the company's longstanding relationships with the Centers for Disease Control and Prevention (CDC) and 49 of the 50 state departments of public health for biosurveillance and public health reporting. Customers interviewed for the report commented on the flexibility of Orion Health's integration tools as well as the configurability of the solution's interfaces. The company also received praise as an excellent partner with responsiveness to customer suggestions.

"The 2012 U.S. HIE MarketScape Report shows that Orion Health continues to innovate, providing connected solutions to our customers in healthcare facilities, organizations and regions in the U.S. and abroad," said Paul Viskovich, president, Orion Health North America. "As the healthcare and HIE market evolves, we're confident that Orion Health will continue to grow in its leadership position and help to create some of the most dynamic and robust HIEs in the country."

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market.

IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

Orion Health HIE, is the technology backbone for enterprise and community-wide clinical data sharing in hospitals, health systems and public HIEs across the U.S. The software enables these organizations to better share critical patient information between provider facilities, HIEs, clinicians and patients; improve care coordination and quality of care; and meet Meaningful Use requirements.

Orion Health HIE enables the easy and secure exchange of clinical data within and between organizations, ensuring all clinicians have access to relevant and accurate patient information – regardless of where care was provided. Orion Health HIE, the technology backbone for enterprise and regional clinical data sharing, provides a foundation for care and disease management solutions and is used by hospitals, health systems and public HIEs across the U.S. The HIE solution offers a collection of components featuring an integration engine, enterprise master patient index (EMPI), physician and patient portals, data repository, customizable notifications, provider index, and analytical and quality reporting tools. Orion Health HIE enhances clinical workflow and enables healthcare organizations to improve care coordination and quality of care, and meet Meaningful Use requirements. For more information please see .

Orion Health, Inc. is the only global, independently owned eHealth software company and is the world's leading provider of health information exchange (HIE) and healthcare integration solutions. Worldwide, Orion Health solutions are used in 30 countries by more than 300,000 clinicians. In the United States, thousands of clinicians and hundreds of provider facilities and OEM partners rely on Orion Health to facilitate data exchange between hospitals, health systems, HIEs, and affiliated clinicians and medical devices, resulting in improved care coordination, increased cost savings and efficiencies, and enhanced quality of care.

In the U.S., Orion Health™ HIE provides the technology backbone for state and regional HIEs across the country. Orion Health Rhapsody® Integration Engine, now celebrating its ten-year anniversary, is used by nearly all state and local health departments for public health reporting. Orion Health's U.S. customers include Catholic Health Initiatives, the Centers for Disease Control and Prevention, Beacon Community of the Inland Northwest, Geisinger Health System, Inland Empire HIE, Kaiser Permanente, Lahey Clinic, Louisiana Health Care Quality Forum, Lehigh Valley Health Network, Maine HealthInfoNet, Ochsner Health System, St. Vincent's HealthCare and UCLA Medical Center. Orion Health's partners include leading health system integrators and IT vendors such as Accenture, Allscripts, IBM, Microsoft, Oracle, Philips and others. For more information, visit: .

Orion Health and Rhapsody are registered trademarks of Orion Health Inc, its parent/or its affiliates. Other names used may be trademarks of their respective owners.

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.